---
$id: https://graph.org.ai/products/commodity/51172333
$type: Product
source: UNSPSC
code: "51172333"
title: "Sugammadex sodium"
class: "51172300"
classTitle: "Antidotes and emetics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sugammadex sodium

**UNSPSC Code**: 51172333
**Class**: [Antidotes and emetics](Antidotes and emetics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ERJ6X2MXV7. European Medicines Agency schedules Sugammadex sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32205. Sugammadex sodium generally arises in the molecular formula C72H104O48S8.8NA. The term 'sugammadex sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule sugammadex sodium under HS 29329985 and SITC 51569. Sugammadex sodium bears US NLM identifiers UMLS ID C2350811 and NCI Concept Code C78123. SMILES: As of Q4 2014, SUGAMMADEX SODIUM remains US FDA's Preferred Term for this commodity.

